U.S. House · 117th Congress · H.R. 1629
Fairness in Orphan Drug Exclusivity Act
To amend the Federal Food, Drug, and Cosmetic Act with respect to limitations on exclusive approval or licensure of orphan drugs, and for other purposes.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Madeleine DeanD-PA-4
- Introduced
- March 8, 2021, in the House
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (2)
Every roll-call vote held on the bill or its amendments, oldest first. Each links to how every member voted.
House · Roll call 134May 11, 2021
On Motion to Suspend the Rules and Pass
Failed
250 Yea168 Nay12 not voting
House · Roll call 150May 19, 2021
On Passage
Passed
402 Yea23 Nay4 not voting
Cosponsors (2)
1 Democrat, 1 Republican. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Marc A. VeaseyD-TX-33
Signed on later
- Brian K. FitzpatrickR-PA-1May 11, 2021